MoneyWorks4Me

Alembic Pharmaceuticals informs about Press Release

27 Mar 2019 Evaluate

Alembic Pharmaceuticals has informed about press release regarding the Company received US Food & Drug Administration (USFDA) Approval for Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg and 20 mg.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..